Open AccessPHASE III RANDOMISED COMPARISON OF GEMCITABINE (GEM) WITH GEMCITABINE PLUS CAPECITABINE (GEM-CAP) IN PATIENTS WITH ADVANCED PANCREATIC CANCER
Author(s) -
John P. Neoptolemos,
Ian Chau,
Deborah Stocken,
Clare C. Davies,
Janet A. Dunn,
Juan W. Valle,
David B. Smith,
William P. Steward,
Peter Harper,
D Cunninghamon
Publication year - 2005
Publication title -
pancreas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.061
H-Index - 104
eISSN - 1536-4828
pISSN - 0885-3177
DOI - 10.1097/01.mpa.0000193729.11792.b3
Subject(s) - gemcitabine , capecitabine , medicine , hazard ratio , interim analysis , gastroenterology , pancreatic cancer , antimetabolite , oncology , toxicity , surgery , cancer , confidence interval , randomized controlled trial , colorectal cancer